Compound details
Geranylcitronellol
| Compound ID | CDAMM01864 |
|---|---|
| Common name | Geranylcitronellol | IUPAC name | 3,7,11,15-tetramethylhexadeca-6,10,14-trien-1-ol |
| Molecular formula | C20H36O |
| Retention time | 9.83 |
|---|---|
| Adduct | [2M+K]+ |
| Actual mz | 623.525 | Theoretical mz | 623.517 |
| Error | 12.74 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.4547 |
| Inchi key | ZKWFMIAGZQACFE-NWLVNBMCNA-N |
|---|---|
| Smiles | OCCC(C)CCC=C(C)CCC=C(C)CCC=C(C)C |
| Superclass | Lipids and lipid-like molecules |
| Class | Prenol lipids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P48449 | LSS | Lanosterol synthase | T56175 | SEA |
| P10275 | AR | Androgen Receptor | T11211 | SwissTargetPrediction |
| P18031 | PTPN1 | Protein-tyrosine phosphatase 1B | T16347 | SwissTargetPrediction |
| Q13133 | NR1H3 | LXR-alpha | T52297 | SwissTargetPrediction |
| Q14534 | SQLE | Squalene monooxygenase (by homology) | T93344 | SwissTargetPrediction and SEA |
| P08172 | CHRM2 | Muscarinic acetylcholine receptor M2 | T46185 | SwissTargetPrediction |
| P49356 | FNTB | Farnesyl protein transferase | T13127 | SEA |
| P34972 | CNR2 | Cannabinoid receptor 2 | T37693 | SwissTargetPrediction |
| P21757 | MSR1 | Macrophage scavenger receptor types I and II | T50007 | SEA |
| P49356 | FNTB | Farnesyl protein transferase | T13127 | SEA |
| O95749 | GGPS1 | Geranyltranstransferase | T86528 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T56175 | DI0035 | Arterial occlusive disease | [ICD-11: BD40] | P48449 | LSS |
| T11211 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P10275 | AR |
| T11211 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10275 | AR |
| T11211 | DI0021 | Alcoholic liver disease | [ICD-11: DB94] | P10275 | AR |
| T11211 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P10275 | AR |
| T11211 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P10275 | AR |
| T11211 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P10275 | AR |
| T11211 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P10275 | AR |
| T11211 | DI0237 | Low bone mass disorder | [ICD-11: FB83] | P10275 | AR |
| T11211 | DI0247 | Mammary tumour | [ICD-11: 2C60-2C6Z] | P10275 | AR |
| T11211 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P10275 | AR |
| T11211 | DI0401 | Testicular dysfunction | [ICD-11: 5A81] | P10275 | AR |
| T16347 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P18031 | PTPN1 |
| T16347 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P18031 | PTPN1 |
| T16347 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18031 | PTPN1 |
| T16347 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P18031 | PTPN1 |
| T52297 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | Q13133 | NR1H3 |
| T93344 | DI0118 | Dermatophytosis | [ICD-11: 1F28] | Q14534 | SQLE |
| T93344 | DI0385 | Skin fungal infection disorder | [ICD-11: EA60] | Q14534 | SQLE |
| T46185 | DI0037 | Asthma | [ICD-11: CA23] | P08172 | CHRM2 |
| T46185 | DI0166 | Glaucoma | [ICD-11: 9C61] | P08172 | CHRM2 |
| T46185 | DI0278 | Muscle disorder | [ICD-11: FB32-FB3Z] | P08172 | CHRM2 |
| T46185 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P08172 | CHRM2 |
| T46185 | DI0362 | Respiratory system disease | [ICD-11: CB40-CB7Z] | P08172 | CHRM2 |
| T46185 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P08172 | CHRM2 |
| T13127 | DI0342 | Premature ageing appearance | [ICD-11: LD2B] | P49356 | FNTB |
| T37693 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P34972 | CNR2 |
| T37693 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P34972 | CNR2 |
| T13127 | DI0342 | Premature ageing appearance | [ICD-11: LD2B] | P49356 | FNTB |
| T86528 | DI0057 | Bone paget disease | [ICD-11: FB85] | O95749 | GGPS1 |
| T86528 | DI0237 | Low bone mass disorder | [ICD-11: FB83] | O95749 | GGPS1 |
| T86528 | DI0267 | Mineral excesses | [ICD-11: 5B91] | O95749 | GGPS1 |
| T86528 | DI0281 | Musculoskeletal disorder | [ICD-11: FA00-FC0Z] | O95749 | GGPS1 |